Advisory Services Network LLC reduced its position in Clorox Co. (NYSE:CLX) by 24.9% during the second quarter, Holdings Channel reports. The firm owned 1,885 shares of the company’s stock after selling 625 shares during the period. Advisory Services Network LLC’s holdings in Clorox were worth $261,000 at the end of the most recent reporting period.
Other institutional investors have also recently modified their holdings of the company. Checchi Capital Advisers LLC raised its position in shares of Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock worth $113,000 after buying an additional 8 shares during the period. Cleararc Capital Inc. increased its stake in shares of Clorox by 0.3% in the first quarter. Cleararc Capital Inc. now owns 3,163 shares of the company’s stock valued at $399,000 after buying an additional 10 shares in the last quarter. Mariner Wealth Advisors LLC increased its stake in shares of Clorox by 0.4% in the first quarter. Mariner Wealth Advisors LLC now owns 2,505 shares of the company’s stock valued at $316,000 after buying an additional 10 shares in the last quarter. Keel Point LLC increased its stake in shares of Clorox by 0.5% in the second quarter. Keel Point LLC now owns 7,512 shares of the company’s stock valued at $1,040,000 after buying an additional 37 shares in the last quarter. Finally, DAVENPORT & Co LLC increased its stake in shares of Clorox by 3.4% in the second quarter. DAVENPORT & Co LLC now owns 3,039 shares of the company’s stock valued at $421,000 after buying an additional 99 shares in the last quarter. Institutional investors own 70.21% of the company’s stock.
Shares of Clorox Co. (NYSE:CLX) traded down 0.07% on Friday, reaching $122.65. 974,005 shares of the company were exchanged. Clorox Co. has a 52-week low of $119.23 and a 52-week high of $140.47. The stock has a 50 day moving average of $126.61 and a 200-day moving average of $129.88. The company has a market capitalization of $15.88 billion, a P/E ratio of 24.93 and a beta of 0.29.
Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, August 3rd. The company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.28 by $0.02. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The company earned $1.60 billion during the quarter, compared to analysts’ expectations of $1.58 billion. During the same period last year, the firm earned $1.44 earnings per share. Clorox’s revenue was up 2.8% on a year-over-year basis. On average, analysts predict that Clorox Co. will post $5.49 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, November 14th. Stockholders of record on Wednesday, October 26th will be issued a $0.80 dividend. The ex-dividend date of this dividend is Monday, October 24th. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.61%. Clorox’s payout ratio is 64.91%.
CLX has been the topic of several analyst reports. Atlantic Securities initiated coverage on Clorox in a research report on Tuesday, June 14th. They set a “neutral” rating and a $138.00 price target on the stock. Zacks Investment Research downgraded Clorox from a “hold” rating to a “sell” rating in a research report on Tuesday, July 5th. Goldman Sachs Group Inc. reaffirmed a “neutral” rating and set a $131.00 price target (up from $125.00) on shares of Clorox in a research report on Friday, July 15th. Deutsche Bank AG reaffirmed a “hold” rating and set a $134.00 price target (up from $130.00) on shares of Clorox in a research report on Sunday, July 24th. Finally, Jefferies Group reaffirmed a “hold” rating on shares of Clorox in a research report on Wednesday, August 3rd. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company’s stock. Clorox has a consensus rating of “Hold” and an average target price of $128.90.
In other news, EVP Laura Stein sold 38,882 shares of the company’s stock in a transaction dated Friday, September 2nd. The shares were sold at an average price of $131.69, for a total value of $5,120,370.58. Following the completion of the sale, the executive vice president now directly owns 48,501 shares of the company’s stock, valued at $6,387,096.69. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO Nikolaos A. Vlahos sold 925 shares of the company’s stock in a transaction dated Wednesday, August 10th. The shares were sold at an average price of $133.07, for a total transaction of $123,089.75. The disclosure for this sale can be found here. 0.74% of the stock is currently owned by insiders.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.